Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 16Thoracic 2Other neoplasm 1Other 1Endocrine 1

Conditions

Precancerous Conditions 5Tongue Neoplasms 1Rectal Neoplasms 1Oropharyngeal Neoplasms 1Nasopharyngeal Neoplasms 1Mouth Neoplasms 1Leukoplakia, Oral 1Keratosis, Actinic 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Adenomatous Polyposis Coli 1

Interventions

Cetuximab 3Radiotherapy, Intensity-Modulated 2Cisplatin 2Video-Assisted Surgery 1Photochemotherapy 1Paclitaxel 1Nivolumab 1Immunohistochemistry 1Gene Expression Profiling 1Dihematoporphyrin Ether 1Comparative Genomic Hybridization 1Celecoxib 1Biopsy 1Aminolevulinic Acid 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × Celecoxib × Other neoplasm × Clear all
NCT00101335 2013-07-11

Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Fox Chase Cancer Center

Phase 2 Completed
Head & NeckOther neoplasm

Head and Neck Neoplasms, Hypopharyngeal Neoplasms, Leukoplakia, Oral, Mouth Neoplasms, Nasopharyngeal Neoplasms, Oropharyngeal Neoplasms, Precancerous Conditions, Tongue Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡